Huons Co., Ltd. acquires stake in PanGen to accelerate biopharmaceutical development
Nov 07, 2024•8 months ago
Acquiring Company
Huons
Acquired Company
PanGen Biotech
Description
Huons Co., Ltd. has announced the acquisition of a significant stake in PanGen Biotech Inc. The acquisition is aimed at expanding Huons' biopharmaceutical research and development expertise, as well as strengthening its contract development and manufacturing organization (CDMO) business. This strategic move is expected to enhance Huons' global competitiveness and lead to synergies between affiliates.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed